UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A systematic review comparing sex differences in cognitive function in schizophrenia and in rodent models for schizophrenia, implications for improved therapeutic strategies

Neuroscience and biobehavioral reviews, 2016-09, Vol.68, p.979-1000

2016

Volltextzugriff (PDF)

Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents

Behavioural brain research, 2015-05, Vol.285, p.176-193

2015

Volltextzugriff (PDF)

Cognitive dysfunction in major depression: From assessment to novel therapies

Pharmacology & therapeutics (Oxford), 2019-10, Vol.202, p.53-71

2019

Volltextzugriff (PDF)

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update

Neuropharmacology, 2018-11, Vol.142, p.41-62

2018

Volltextzugriff (PDF)

Novel antidepressant drugs: Beyond monoamine targets

CNS spectrums, 2023-02, Vol.28 (1), p.6-15

2023

Volltextzugriff (PDF)

Maternal immune activation in rodent models: A systematic review of neurodevelopmental changes in gene expression and epigenetic modulation in the offspring brain

Neuroscience and biobehavioral reviews, 2021-10, Vol.129, p.389-421

2021

Volltextzugriff (PDF)

Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects

Brain, behavior, and immunity, 2019-01, Vol.75, p.48-59

2019

Volltextzugriff (PDF)

Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study

JAMA psychiatry (Chicago, Ill.), 2022-05, Vol.79 (5), p.498

2022

Volltextzugriff (PDF)

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

Pharmacology & therapeutics (Oxford), 2010-12, Vol.128 (3), p.419-432

2010

Volltextzugriff (PDF)

Partial agonism at the α7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive rats

European neuropsychopharmacology, 2017-04, Vol.27 (4), p.325-335

2017

Volltextzugriff (PDF)

Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model

Behavioural brain research, 2016-10, Vol.312, p.93-101

2016

Volltextzugriff (PDF)

Low attentive and high impulsive rats: A translational animal model of ADHD and disorders of attention and impulse control

Pharmacology & therapeutics (Oxford), 2016-02, Vol.158, p.41-51

2016

Volltextzugriff (PDF)

Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model

Psychological medicine, 2023-12, Vol.53 (16), p.7619-7626

2023

Volltextzugriff (PDF)

Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856

International journal of molecular sciences, 2021-04, Vol.22 (8), p.4119

2021

Volltextzugriff (PDF)

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans

European neuropsychopharmacology, 2014-05, Vol.24 (5), p.822-835

2014

Volltextzugriff (PDF)

Maternal immune activation in rats induces dysfunction of placental leucine transport and alters fetal brain growth

Clinical science (1979), 2022-08, Vol.136 (15), p.1117-1137

2022

Volltextzugriff (PDF)

Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials

The Lancet. Psychiatry, 2021-06, Vol.8 (6), p.471-486

2021

Volltextzugriff (PDF)

Improvement of phencyclidine-induced social behaviour deficits in rats : Involvement of 5-HT1A receptors

Behavioural brain research, 2008-08, Vol.191 (1), p.26-31

2008

Volltextzugriff (PDF)

Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine

Journal of Psychopharmacology, 2016-11, Vol.30 (11), p.1141-1144

2016

Volltextzugriff (PDF)

The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia

Neuropharmacology, 2022-05, Vol.208, p.108982-108982, Article 108982

2022

Volltextzugriff (PDF)

Maternal behaviours and adult offspring behavioural deficits are predicted by maternal TNFα concentration in a rat model of neurodevelopmental disorders

Brain, behavior, and immunity, 2023-02, Vol.108, p.162-175

2023

Volltextzugriff (PDF)

The involvement of distraction in memory deficits induced by NMDAR antagonism: Relevance to cognitive deficits in schizophrenia

Behavioural brain research, 2014-06, Vol.266, p.188-192

2014

Volltextzugriff (PDF)

Pharmacology of cognition: a panacea for neuropsychiatric disease?

British journal of pharmacology, 2017-10, Vol.174 (19), p.3133-3135

2017

Volltextzugriff (PDF)

Putative therapeutic targets for symptom subtypes of adult ADHD: D4 receptor agonism and COMT inhibition improve attention and response inhibition in a novel translational animal model

European neuropsychopharmacology, 2015-04, Vol.25 (4), p.454-467

2015

Volltextzugriff (PDF)

Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors

Psychopharmacologia, 2009-11, Vol.207 (1), p.119-125

2009

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Englisch
(164)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A systematic review comparing sex differences in cognitive function in schizophrenia and in rodent models for schizophrenia, implications for improved therapeutic strategies

Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents

Cognitive dysfunction in major depression: From assessment to novel therapies

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update

Novel antidepressant drugs: Beyond monoamine targets

Maternal immune activation in rodent models: A systematic review of neurodevelopmental changes in gene expression and epigenetic modulation in the offspring brain

Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects

Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

Partial agonism at the α7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive rats

Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model

Low attentive and high impulsive rats: A translational animal model of ADHD and disorders of attention and impulse control

Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model

Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans

Maternal immune activation in rats induces dysfunction of placental leucine transport and alters fetal brain growth

Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials

Improvement of phencyclidine-induced social behaviour deficits in rats : Involvement of 5-HT1A receptors

Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine

The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia

Maternal behaviours and adult offspring behavioural deficits are predicted by maternal TNFα concentration in a rat model of neurodevelopmental disorders

The involvement of distraction in memory deficits induced by NMDAR antagonism: Relevance to cognitive deficits in schizophrenia

Pharmacology of cognition: a panacea for neuropsychiatric disease?

Putative therapeutic targets for symptom subtypes of adult ADHD: D4 receptor agonism and COMT inhibition improve attention and response inhibition in a novel translational animal model

Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors

Suchergebnisse filtern